LONGEVA.

Epithalamin: side effects and evidence limits

The Epithalamin listing names a pineal polypeptide complex supplied as lyophilized powder [1]. This mixture must remain distinct from synthetic Epitalon/AEDG: the inspected analytical sections identify AEDG as only one constituent of the studied complex [2].

The inspected methods and results passage of a 2006 paper concern a historical epithalamin preparation in older coronary patients. Intramuscular courses spanned three years, with 12 years of observation. The authors gave a positive qualitative tolerability assessment [3].

That assessment is not an established incidence of causally attributed adverse reactions. Selected sections of the scanned paper were read, rather than a complete harms audit. Follow-up duration is not treatment duration; equivalence of the historical preparation and current powder remains unverified. These data do not establish clinical safety of the current product [1–3].

What the studies reported

EffectModel or participantsHow often or as describedSource
Tolerability of the historical epithalamin preparationOlder patients with coronary disease, intramuscular courses over three years, 12 years of observationThe authors gave a positive qualitative tolerability assessment; there is no established incidence of causally attributed adverse reactions, and no complete harms audit was performed[3]
Applicability of the historical data to the current productPineal polypeptide complex (a mixture); AEDG is only one of its constituentsEquivalence of the historical preparation and the current powder remains unverified; these data do not establish clinical safety of the current product[1][2]

References

  1. Longeva (2026). Epithalamin product identity https://longeva.bio/en/product/epithalamin.
  2. Khavinson VK et al. (2017). Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland https://link.springer.com/article/10.1007/s10517-017-3922-8 doi:10.1007/s10517-017-3922-8.
  3. Korkushko OV et al. (2006). Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging https://link.springer.com/article/10.1007/s10517-006-0365-z doi:10.1007/s10517-006-0365-z.